BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37240029)

  • 1. TGF-β Type I Receptor Signaling in Melanoma Liver Metastases Increases Metastatic Outgrowth.
    Marvin DL; Dijkstra J; Zulfiqar RM; Vermeulen M; Ten Dijke P; Ritsma L
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.
    Liu C; Li J; Xiang X; Guo L; Tu K; Liu Q; Shah VH; Kang N
    Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(7):G749-59. PubMed ID: 25169976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of ALK5 inhibition and simultaneous inhibition or activation of HIF-1α in melanoma tumor growth and angiogenesis.
    Zarin B; Nedaeinia R; Laher I; Manian M; Javanmard SH
    Tumour Biol; 2023; 45(1):111-126. PubMed ID: 37927290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of endothelial barrier function by TGF-β type I receptor ALK5: potential role of contractile mechanisms and heat shock protein 90.
    Antonov AS; Antonova GN; Fujii M; ten Dijke P; Handa V; Catravas JD; Verin AD
    J Cell Physiol; 2012 Feb; 227(2):759-71. PubMed ID: 21465483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.
    Melisi D; Ishiyama S; Sclabas GM; Fleming JB; Xia Q; Tortora G; Abbruzzese JL; Chiao PJ
    Mol Cancer Ther; 2008 Apr; 7(4):829-40. PubMed ID: 18413796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of transmembrane receptor tyrosine kinase DDR1-STAT3 cascade by extracellular matrix remodeling promotes liver metastatic colonization in uveal melanoma.
    Dai W; Liu S; Wang S; Zhao L; Yang X; Zhou J; Wang Y; Zhang J; Zhang P; Ding K; Li Y; Pan J
    Signal Transduct Target Ther; 2021 May; 6(1):176. PubMed ID: 33976105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis.
    Wang HX; Sharma C; Knoblich K; Granter SR; Hemler ME
    Cell Res; 2015 Mar; 25(3):370-85. PubMed ID: 25656846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte-specific expression of constitutively active Alk5 exacerbates thioacetamide-induced liver injury in mice.
    Kongphat W; Pudgerd A; Sridurongrit S
    Heliyon; 2017 May; 3(5):e00305. PubMed ID: 28560358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta.
    Ungefroren H; Groth S; Ruhnke M; Kalthoff H; Fändrich F
    J Biol Chem; 2005 Jan; 280(4):2644-52. PubMed ID: 15546867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes.
    Weng HL; Ciuclan L; Liu Y; Hamzavi J; Godoy P; Gaitantzi H; Kanzler S; Heuchel R; Ueberham U; Gebhardt R; Breitkopf K; Dooley S
    Hepatology; 2007 Oct; 46(4):1257-70. PubMed ID: 17657819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
    Yoo YA; Kang MH; Kim JS; Oh SC
    Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
    Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
    Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory expression of genes related to metastasis by TGF-beta and activin A in B16 murine melanoma cells.
    Murakami M; Suzuki M; Nishino Y; Funaba M
    Mol Biol Rep; 2010 Mar; 37(3):1279-86. PubMed ID: 19288218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.
    Zeeh F; Witte D; Gädeken T; Rauch BH; Grage-Griebenow E; Leinung N; Fromm SJ; Stölting S; Mihara K; Kaufmann R; Settmacher U; Lehnert H; Hollenberg MD; Ungefroren H
    Oncotarget; 2016 Jul; 7(27):41095-41109. PubMed ID: 27248167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tumor cell-derived TGF-β on macrophage phenotype and macrophage-mediated tumor cell invasion.
    Maldonado LAG; Nascimento CR; Rodrigues Fernandes NA; Silva ALP; D'Silva NJ; Rossa C
    Int J Biochem Cell Biol; 2022 Dec; 153():106330. PubMed ID: 36343916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of TGF-β Signaling on Cancer Cells and Cancer Stem Cells in the Bone Microenvironment.
    Futakuchi M; Lami K; Tachibana Y; Yamamoto Y; Furukawa M; Fukuoka J
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31619018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
    Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
    Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.
    Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW
    Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C18 ORF1, a novel negative regulator of transforming growth factor-β signaling.
    Nakano N; Maeyama K; Sakata N; Itoh F; Akatsu R; Nakata M; Katsu Y; Ikeno S; Togawa Y; Vo Nguyen TT; Watanabe Y; Kato M; Itoh S
    J Biol Chem; 2014 May; 289(18):12680-92. PubMed ID: 24627487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.